Innate Pharma buy Lokrim
Start price
05.09.21
/
10%
€4.80
Target price
05.09.22
-
Performance (%)
-47.79%
End price
07.03.22
€2.51
Summary
This prediction ended on 07.03.22 with a price of €2.51. The BUY prediction by Lokrim for Innate Pharma performed very badly with a performance of -47.79%. Lokrim has 10% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innate Pharma | 1.361% | 1.361% | -21.716% |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% |
According to Lokrim what are the pros and cons of Innate Pharma for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Innate Pharma diskutieren
Buy Innate Pharma
In the thread Trading Innate Pharma
Stopped prediction by Lokrim for Innate Pharma
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
